Literature DB >> 33194026

Upregulation of CSF-1 is correlated with elevated TAM infiltration and poor prognosis in oral squamous cell carcinoma.

Xiao-Yu Guo1,2, Jia-Yi Zhang1,3, Xin-Zhan Shi1,4, Qiong Wang1,3, Wei-Li Shen1,3, Wei-Wen Zhu1,3, Lai-Kui Liu1,3.   

Abstract

Mounting lines of evidence indicated that the "colony stimulating factor-1 (CSF-1)/tumor-associated macrophage (TAM)" signature plays an important role in the progression, invasion and metastasis of multiple tumors. However, the potential role of CSF-1/TAM in oral squamous cell carcinoma (OSCC) remains largely unknown. In the present study, the expression of CSF-1 from 99 OSCC specimens and its correlation with clinicopathological features and patient outcomes were investigated. Meanwhile, the correlation between CSF-1 expression and TAM infiltration was also explored. To investigate the potential effect of CSF-1 on tumor growth, nude mice were subcutaneously injected with Cal27 cell line and a small molecule inhibitor of CSF-1 (BZL945). The results showed that the high expression rate of CSF-1 (52%) was found in OSCC, and the upregulation of CSF-1 was closely correlated with lymph node metastasis and clinical stage. Additionally, there was a positive correlation between a high CSF-1 level and elevated TAM infiltration. The xenograft model study showed that CSF-1 signal blockade inhibited tumor growth, with a significant synchronous decrease in CSF-1 expression and TAM infiltration. Overall, our findings indicated that CSF-1 plays a crucial role in TAMs-mediated OSCC tumor progression and invasion. The "CSF-1/TAM" signaling axis may serve as a prospective target for anti-tumor therapy of OSCC. AJTR
Copyright © 2020.

Entities:  

Keywords:  Macrophage colony stimulating factor-1; oral squamous cell carcinoma; tumor microenvironment; tumor-associated macrophages

Year:  2020        PMID: 33194026      PMCID: PMC7653598     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  50 in total

1.  Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival.

Authors:  I F Lissbrant; P Stattin; P Wikstrom; J E Damber; L Egevad; A Bergh
Journal:  Int J Oncol       Date:  2000-09       Impact factor: 5.650

2.  World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015.

Authors:  Shelley McGuire
Journal:  Adv Nutr       Date:  2016-03-15       Impact factor: 8.701

3.  Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop.

Authors:  Sumanta Goswami; Erik Sahai; Jeffrey B Wyckoff; Michael Cammer; Dianne Cox; Fiona J Pixley; E Richard Stanley; Jeffrey E Segall; John S Condeelis
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

Review 4.  Macrophages, innate immunity and cancer: balance, tolerance, and diversity.

Authors:  Alberto Mantovani; Antonio Sica
Journal:  Curr Opin Immunol       Date:  2010-02-09       Impact factor: 7.486

Review 5.  Colony-stimulating factor-1 in immunity and inflammation.

Authors:  Violeta Chitu; E Richard Stanley
Journal:  Curr Opin Immunol       Date:  2005-12-06       Impact factor: 7.486

6.  Quantitative Assessment of Tumor Associated Macrophages in Head and Neck Squamous Cell Carcinoma Using CD68 Marker: An Immunohistochemical Study.

Authors:  Neeta Bagul; Souparna Roy; Anjali Ganjre; Rahul Kathariya; Aishwarya Meher; Pratibha Singh
Journal:  J Clin Diagn Res       Date:  2016-04-01

7.  Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma.

Authors:  Inigo Espinosa; Andrew H Beck; Cheng-Han Lee; Shirley Zhu; Kelli D Montgomery; Robert J Marinelli; Kristen N Ganjoo; Torsten O Nielsen; C Blake Gilks; Robert B West; Matt van de Rijn
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

Review 8.  Diverse macrophages polarization in tumor microenvironment.

Authors:  Inmoo Rhee
Journal:  Arch Pharm Res       Date:  2016-08-25       Impact factor: 4.946

9.  Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis.

Authors:  S M Scholl; C Pallud; F Beuvon; K Hacene; E R Stanley; L Rohrschneider; R Tang; P Pouillart; R Lidereau
Journal:  J Natl Cancer Inst       Date:  1994-01-19       Impact factor: 13.506

10.  M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis.

Authors:  Yoshiaki Kubota; Keiyo Takubo; Takatsune Shimizu; Hiroaki Ohno; Kazuo Kishi; Masabumi Shibuya; Hideyuki Saya; Toshio Suda
Journal:  J Exp Med       Date:  2009-04-27       Impact factor: 14.307

View more
  4 in total

1.  Assessing the effect of human dental pulp mesenchymal stem cell secretome on human oral, breast, and melanoma cancer cell lines.

Authors:  A Thirumal Raj; Supriya Kheur; Ramesh Bhonde; Vishnu R Mani; Hosam Ali Baeshen; Shankargouda Patil
Journal:  Saudi J Biol Sci       Date:  2021-07-14       Impact factor: 4.219

2.  Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers.

Authors:  Samantha M Y Chen; Vince Popolizio; Rachel A Woolaver; Huaibin Ge; Alexandra L Krinsky; Jessy John; Etienne Danis; Yao Ke; Yonatan Kramer; Li Bian; Andrew G Nicklawsky; Dexiang Gao; Silvia Liu; Zhangguo Chen; Xiao-Jing Wang; Jing H Wang
Journal:  J Exp Clin Cancer Res       Date:  2022-04-02

Review 3.  The role of tumor-associated macrophages in oral squamous cell carcinoma.

Authors:  Yiwen Xue; Xiao Song; Siyu Fan; Runzhi Deng
Journal:  Front Physiol       Date:  2022-08-29       Impact factor: 4.755

Review 4.  Mitochondrial DNA on Tumor-Associated Macrophages Polarization and Immunity.

Authors:  Yaxin Guo; Hsiang-I Tsai; Lirong Zhang; Haitao Zhu
Journal:  Cancers (Basel)       Date:  2022-03-11       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.